For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| 13vPnC Group 1 (Preterm Infant) - Infant Series | Preterm infant participants (GA \<37 weeks) who received single 0.5 mL dose of 13vPnC intramuscularly at 2, 3 and 4 months of age (infant series), assessed from Infant Dose 1 through the blood draw 1 month after Infant Dose 3. | None | None | 14 | 100 | 98 | 100 | View |
| 13vPnC Group 2 (Term Infant) - Infant Series | Term infant participants (GA \>=37 weeks) who received single 0.5 mL dose of 13vPnC intramuscularly at 2, 3, 4 months of age (infant series), assessed from Infant Dose 1 through the blood draw 1 month after Infant Dose 3. | None | None | 5 | 100 | 99 | 100 | View |
| 13vPnC Group 1 (Preterm Infant) - After Infant Series | Preterm infant participants (GA \<37 weeks) who received single 0.5 mL dose of 13vPnC intramuscularly at 2, 3 and 4 months of age (infant series), assessed from blood draw 1 month after infant Dose 3 to before toddler dose. | None | None | 8 | 100 | 13 | 100 | View |
| 13vPnC Group 2 (Term Infant) - After Infant Series | Term infant participants (GA \>=37 weeks) who received single 0.5 mL dose of 13vPnC intramuscularly at 2, 3, 4 months of age (infant series), assessed from blood draw 1 month after infant Dose 3 to before toddler dose. | None | None | 9 | 100 | 11 | 100 | View |
| 13vPnC Group 1 (Preterm Infant) - Toddler Dose | Preterm infant participants (GA \<37 weeks) who received single 0.5 mL dose of 13vPnC intramuscularly at 2, 3, 4 months of age (infant series) and 12 months of age (toddler dose), assessed from the toddler dose through the blood draw 1 month after toddler dose. | None | None | 2 | 99 | 93 | 99 | View |
| 13vPnC Group 2 (Term Infant) - Toddler Dose | Term infant participants (GA \>=37 weeks) who received single 0.5 mL dose of 13vPnC intramuscularly at 2, 3, 4 months of age (infant series) and 12 months of age (toddler dose), assessed from the toddler dose through the blood draw 1 month after toddler dose. | None | None | 1 | 97 | 92 | 97 | View |
| 13vPnC Group 1 (Preterm Infant) - 1 Year Follow-up | Preterm infant participants (GA \<37 weeks) who received single 0.5 mL dose of 13vPnC intramuscularly at 2, 3, 4 months of age (infant series) and 12 months of age (toddler dose), assessed from blood draw 1 month after the toddler dose to 1-year follow-up. | None | None | 13 | 99 | 2 | 99 | View |
| 13vPnC Group 2 (Term Infant) - 1 Year Follow-up | Term infant participants (GA \>=37 weeks) who received single 0.5 mL dose of 13vPnC intramuscularly at 2, 3, 4 months of age (infant series) and 12 months of age (toddler dose), assessed from blood draw 1 month after the toddler dose to 1-year follow-up. | None | None | 8 | 97 | 0 | 97 | View |
| 13vPnC Group 1 (Preterm Infant) - 2 Year Follow-up | Preterm infant participants (GA \<37 weeks) who received single 0.5 mL dose of 13vPnC intramuscularly at 2, 3, 4 months of age (infant series) and 12 months of age (toddler dose), assessed from 1-year follow-up after toddler dose to 2-year follow-up after toddler dose. | None | None | 6 | 88 | 1 | 88 | View |
| 13vPnC Group 2 (Term Infant) - 2 Year Follow-up | Term infant participants (GA \>=37 weeks) who received single 0.5 mL dose of 13vPnC intramuscularly at 2, 3, 4 months of age (infant series) and 12 months of age (toddler dose), assessed from 1-year follow-up after toddler dose to 2-year follow-up after toddler dose. | None | None | 8 | 88 | 1 | 88 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA (Unspecified) | View |
| Gastrooesophageal reflux disease | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Inguinal hernia, obstructive | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Diarrhoea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Intussusception | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Stomatitis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Adenoviral upper respiratory infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Bronchiolitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Bronchitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Gastroenteritis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Pneumonia respiratory syncytial viral | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Pyelonephritis acute | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Respiratory syncytial virus bronchiolitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Upper respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Bronchopneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Human herpesvirus 6 infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Viral rash | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Gastroenteritis rotavirus | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Appendicitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Pneumonia mycoplasmal | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Pneumonia viral | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Cellulitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Encephalitis viral | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Laryngitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Meningitis viral | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Otitis media acute | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Viral infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Dehydration | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA | View |
| Ovarian cyst torsion | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDRA | View |
| Bronchial hyperreactivity | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Febrile convulsion | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Hydrocephalus | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Loss of consciousness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Depressed level of consciousness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Hip dysplasia | NON_SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | MedDRA | View |
| Cerebral palsy | NON_SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | MedDRA | View |
| Autism spectrum disorder | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDRA (Unspecified) | View |
| Arthritis reactive | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA | View |
| Respiratory syncytial virus infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Head injury | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA (Unspecified) | View |
| Tibia fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA | View |
| CSF shunt operation | NON_SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | MedDRA | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anaemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDRA (Unspecified) | View |
| Craniotabes | NON_SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | MedDRA | View |
| Hydrocele | NON_SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | MedDRA | View |
| Conjunctivitis | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA | View |
| Eye discharge | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA | View |
| Abdominal pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Pharyngitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Respiratory tract infection bacterial | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Respiratory tract infection viral | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Rhinitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Upper respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Urinary tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Viral infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA (Unspecified) | View |
| Viral rash | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Viral upper respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Cardiac murmur | NON_SYSTEMATIC_ASSESSMENT | Investigations | MedDRA | View |
| Decreased appetite | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA | View |
| Arthralgia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA | View |
| Skin papilloma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | View |
| Hypersomnia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Hypotonia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Subdural hygroma | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Allergic respiratory disease | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Dermatitis | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Dermatitis allergic | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Dermatitis atopic | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Dermatitis diaper | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Dry skin | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Erythema | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Seborrhoeic dermatitis | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA | View |
| Beckwith-Wiedemann syndrome | NON_SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | MedDRA | View |
| Allergy to arthropod sting | NON_SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA | View |
| Loss of consciousness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Teething | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Bronchopneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Herpangina | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Tonsillitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Febrile convulsion | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |
| Developmental delay | NON_SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Tenderness- Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Severe | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Severe | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Tenderness- Severe | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Severe | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Severe | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Severe | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Fever >=38 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >=38 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >=38 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >=38 degrees C, =<39 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >=38 degrees C, =<39 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >=38 degrees C, =<39 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >=39 degrees C, =<40 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >=39 degrees C, =<40 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >=39 degrees C, =<40 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >40 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >40 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Fever >40 degrees C | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Any | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Any | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Any | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Severe | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Severe | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Decreased Appetite- Severe | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Any | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Any | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Any | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Severe | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Severe | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Increased Sleep- Severe | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep- Any | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep- Any | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep- Any | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep- Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep- Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep- Mild | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep-Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep-Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep-Moderate | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep- Severe | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep- Severe | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability or Decreased Sleep- Severe | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Use of Antipyretic Medication | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Use of Antipyretic Medication | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Use of Antipyretic Medication | SYSTEMATIC_ASSESSMENT | General disorders | Systemic Events | View |
| Irritability | NON_SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Pyrexia | NON_SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Cholelithiasis | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | MedDRA | View |
| Food allergy | NON_SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA | View |
| Milk allergy | NON_SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA | View |
| Acute sinusitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Bronchiolitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Bronchitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Ear infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Exanthema subitum | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Gastroenteritis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Influenza | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Laryngitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Nasopharyngitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Oral candidiasis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Otitis media | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Otitis media acute | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA | View |
| Aphthous stomatitis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Diarrhoea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Dyspepsia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Gastrooesophageal reflux disease | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Infantile colic | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Umbilical hernia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA | View |
| Injection site erythema | NON_SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Injection site swelling | NON_SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Swelling- Mild | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Moderate | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Severe | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Severe | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Swelling- Severe | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |
| Redness- Any | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Local Reactions | View |